Digital Mammography Receives FDA Clearance
WAUKESHA, Wis., April 22 -- The US Food and Drug Administration (FDA) has approved the use of R2 Technology Inc.'s mammography CAD technology with GE Medical System's Senographe full-field digital mammography system.
Computer-aided detection (CAD) is used by increasing numbers of radiologists as "a second pair of eyes" when reading a woman's mammogram. Analogous to a spellchecker system on a personal computer, this technology has the potential to detect findings that might otherwise be overlooked during the review process, thus increasing cancer detection.
R2's ImageChecker system was originally approved by the FDA in 1998 for use with film-based screening mammography to assist radiologists in minimizing false-negative readings, and in 2001 the FDA expanded approval to include use with diagnostic mammograms.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024